The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort

Objective. With depression being present in approximately 20% of people with type 2 diabetes mellitus (T2DM), we expect equally frequent prescription of antidepressants, anxiolytics, and hypnotics. Nevertheless, prescription data in people with T2DM is missing and the effect of depression on glycaem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mast, R., Rauh, S. P., Groeneveld, L., Koopman, A. D., Beulens, J. W. J., Jansen, A. P. D., Bremmer, M., van der Heijden, A. A. W. A., Elders, P. J., Dekker, J. M., Nijpels, G., Hugtenburg, J. G., Rutters, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292378/
https://www.ncbi.nlm.nih.gov/pubmed/28232942
http://dx.doi.org/10.1155/2017/5134602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292378/
https://www.ncbi.nlm.nih.gov/pubmed/28232942
http://dx.doi.org/10.1155/2017/5134602

Ejemplares similares